Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Co Expression Vector Technology. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN114634944A details a novel co-expression vector method for Atorvastatin intermediates, offering significant cost reduction and enhanced supply chain reliability for pharmaceutical manufacturers.